TXG · 10x Genomics, Inc.
$56.09
-2.06 (-3.54%)
At close · Aug 14
Market Cap
$7.31B
Shares
130.29M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-07 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-06-08 | 2026-06-04 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-24 | 2026-06-04 | |
| 10-K | 2026-02-13 | 2025-12-31 | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2026-01-12 | 2026-01-11 | |
| 8-K | 2025-11-14 | 2025-11-12 | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-08-08 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-06-05 | 2025-06-03 | |
| Investor Event Transcript | 2025-06-03 | 2025-06-30 | |
| 8-K | 2025-05-14 | 2025-05-12 | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-08 | 2025-05-06 | |
| DEF 14A | 2025-04-14 | 2025-06-03 | |
| 10-K | 2025-02-13 | 2024-12-31 | |
| 8-K | 2025-02-12 | — | |
| 8-K | 2025-01-13 | 2025-01-12 | |
| 10-Q | 2024-10-29 | 2024-09-30 | |
| 8-K | 2024-10-29 | 2024-10-24 | |
| 8-K | 2024-10-09 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | 2024-08-06 | |
| 8-K | 2024-07-11 | 2024-07-10 | |
| 8-K | 2024-06-20 | 2024-06-18 | |
| 8-K | 2024-06-13 | 2024-06-11 | |
| 8-K | 2024-04-30 | — | |
| 10-Q | 2024-04-30 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2024-06-11 | |
| 8-K | 2024-02-15 | — | |
| 10-K | 2024-02-15 | 2023-12-31 | |
| 8-K | 2024-01-16 | 2024-01-15 | |
| 8-K | 2024-01-08 | — | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 10-Q | 2023-08-04 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-07-20 | 2023-07-18 | |
| 8-K | 2023-06-16 | 2023-06-14 | |
| 8-K | 2023-05-17 | — | |
| 10-Q | 2023-05-04 | 2023-03-31 | |
| 8-K | 2023-05-03 | — | |
| DEF 14A | 2023-04-28 | 0001-01-01 | |
| 10-K | 2023-02-16 | 2022-12-31 | |
| 8-K | 2023-02-15 | — |
Showing 1–50 of 91 filings
Key facts
CIK
1770787
CUSIP
88025U109
13F (30d)
365 filings
356 filers
Visit website
Investor relations